Orchid Pharma Ltd - 524372 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Regulation 24(A) - Annual Secretarial Compliance Audit report for the Financial year ended March 31,202229-05-2022
29-05-2022
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 23(9) Of The SEBI (LODR) Regulations For The Half Year Ended March 31,2022
Disclosure under Regulation 23(9) of the SEBI (LODR) regulations for the half year ended March 31,202226-05-2022
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Revised Outcome
Revised outcome - Audited financial results-March 31,2022-Legible format17-05-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publications-Audited financial results for the quarter and year ended March 31,202216-05-2022
Orchid Pharma Ltd - 524372 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Orchid Pharma Ltd 2 CIN NO. L24222TN1992PLC022994 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2020-2021,2021-2022 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-2021,2021-2022 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-NikitaDesignation :-Company Secretary Name of the Chief Financial Officer :- Sunil Gupta Designation : -Chief financial officer Date: 15/05/202215-05-2022
Orchid Pharma Ltd - 524372 - Audited Financial Results For The Financial Year Ended March 31,2022
Audited financial results for the financial year ended March 31,202212-05-2022
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting-May 12,2022
Outcome of Board meeting-May 12,2022-Approval of Audited financial results-March 31,202212-05-2022
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Intimation Of Board Meeting- May 12,2022
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve the Audited financial results (Standalone and Consolidated) for the financial year ended March 31,202205-05-2022
Orchid Pharma Ltd - 524372 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayOrchid Pharma Ltd 2CINL24222TN1992PLC022994 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 245.11 4Highest Credit Rating during the previous FY FORBANKFACILITIES-CAREBBB-CWD-CAREA3CWD 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Nikita K Designation: Company Secretary EmailId: nikitak@orchidpharma.com Name of the Chief Financial Officer: Sunil Kumar Gupta Designation: Chief Financial Officer EmailId: sunilgupta@orchidpharma.com Date: 28/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.28-04-2022